Abstract
Background
Myelomeningocele (MMC) is highly prevalent in developing countries, and MMC-related neurogenic bladder is an important cause of childhood chronic kidney disease (CKD). This nationwide study aimed to evaluate demographic and clinical features of pediatric patients with MMC in Turkey and risk factors associated with CKD stage 5.
Methods
Data from children aged 0–19 years old, living with MMC in 2022, were retrospectively collected from 27 pediatric nephrology centers. Patients > 1 year of age without pre-existing kidney abnormalities were divided into five groups according to eGFR; CKD stages 1–5. Patients on dialysis, kidney transplant recipients, and those with eGFR < 15 ml/min/1.73 m2 but not on kidney replacement therapy at time of study constituted the CKD stage 5 group.
Results
A total of 911 (57.8% female) patients were enrolled, most of whom were expectantly managed. Stages 1–4 CKD were found in 34.3%, 4.2%, 4.1%, and 2.4%, respectively. CKD stage 5 was observed in 5.3% of patients at median 13 years old (range 2–18 years). Current age, age at first abnormal DMSA scan, moderate-to-severe trabeculated bladder on US and/or VCUG, and VUR history were independent risk factors for development of CKD stage 5 (OR 0.752; 95%; CI 0.658–0.859; p < 0.001; OR 1.187; 95% CI 1.031–1.367; p = 0.017; OR 10.031; 95% CI 2.210–45.544; p = 0.003; OR 2.722; 95% CI 1.215–6.102; p = 0.015, respectively). Only eight CKD stage 5 patients underwent surgery related to a hostile bladder between 1 and 15 years old.
Conclusion
MMC-related CKD is common in childhood in Turkey. A proactive approach to neurogenic bladder management and early protective surgery in selected cases where conservative treatment has failed should be implemented to prevent progressive kidney failure in the pediatric MMC population in our country.
Graphical abstract
A higher resolution version of the Graphical abstract is available as Supplementary information
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data are available on request from the authors.
References
Au KS, Ashley-Koch A, Northrup H (2010) Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 16:6–15
Koch VH, Lopes M, Furusawa E, Vaz K, Barroso U (2023) Multidisciplinary management of people with spina bifida across the lifespan. Pediatr Nephrol. https://doi.org/10.1007/s00467-023-06067-w
Sahmat A, Gunasekaran R, Mohd-Zin SW et al (2017) The prevalence and distribution of spina bifida in a single major referral center in Malaysia. Front Pediatr 5:237
Çaylan N, Yalçin SS, Tezel B, Aydin Ş, Üner O, Kara F (2022) Evaluation of neural tube defects from 2014 to 2019 in Turkey. BMC Pregnancy Childbirth 22:340
Shin M, Besser LM, Siffel C, Kucik JE, Shaw GM, Lu C, Correa A, Prevalence Congenital Anomaly Multistate, Collaborative Survival (2010) Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics 126:274–279
Sager C, Barroso U Jr, Netto BJM, Retamal G, Ormaechea E (2022) Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. Int Braz J Urol 48:31–51
de Jong TP, Chrzan R, Klijn AJ, Dik P (2008) Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol 23:889–896
Tanaka ST, Yerkes EB, Routh JC, Tu DD, Austin JC, Wiener JS et al (2021) Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: findings from the UMPIRE multi-center study. J Pediatr Urol 17:726–732
Kari JA, Safdar O, Jamjoom R, Anshasi W (2009) Renal involvement in children with spina bifida. Saudi J Kidney Dis Transpl 20:102–105
Bek K, Akman S, Bilge I, Topaloğlu R, Calişkan S, Peru H et al (2009) Chronic kidney disease in children in Turkey. Pediatr Nephrol 24:797–806
Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44(Suppl 3):4–13
Hacettepe University Institute of Population Studies (2018) Turkey Demographic and Health Survey. Ankara: Hacettepe University Institute of Population Studies, T.R. Presidency of Turkey Directorate of Strategy and Budget and TÜBİTAK; 2019
Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637
KDIGO (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
Joseph DB, Baum MA, Tanaka ST, Frimberger DC, Misseri R, Khavari R et al (2020) Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med 13:479–489
Muller T, Arbeiter K, Aufricht C (2002) Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 12:479–484
Kanaheswari Y, Mohd Rizal AM (2015) Renal scarring and chronic kidney disease in children with spina bifida in a multidisciplinary Malaysian centre. J Paediatr Child Health 51:1175–1181
Sager C, Burek C, Corbetta JP, Weller S, Ruiz J, Perea R (2017) Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele. J Pediatr Urol 13:271.e1-271.e5
Ozel SK, Dokumcu Z, Akyildiz C, Avanoglu A, Ulman I (2007) Factors affecting renal scar development in children with spina bifida. Urol Int 79:133–136
DeLair SM, Eandi J, White MJ, Nguyen T, Stone AR, Kurzrock EA (2007) Renal cortical deterioration in children with spinal dysraphism: analysis of risk factors. J Spinal Cord Med 30:S30-34
Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49:908–913
Hopps C, Kropp K (2003) Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close follow-up. J Urol 169:305–308
Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJ et al (2020) EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment. Neurourol Urodyn 39:45–57
Shiroyanagi Y, Suzuki M, Matsuno D, Yamazaki Y (2009) The significance of 99mtechnetium dimercapto-succinic acid renal scan in children with spina bifida during long-term follow-up. J Urol 181:2262–2266
Cascio S, Doyle M, Mc Mahon O, Kelly G (2021) Urinary tract imaging in infants with spina bifida: a selective approach to a baseline DMSA. J Pediatr Urol 17:396.e1-396.e6
Abrahamsson K, Jodal U, Sixt R, Olsson I, Sillen U (2008) Estimation of renal function in children and adolescents with spinal dysraphism. J Urol 179:2407e9
Szymanski KM, Szymanski AJ, Salama AK, Hains DS, Cain MP, Misseri R (2020) Estimating and tracking renal function in children and adults with spina bifida. J Pediatr Urol 16:169–177
Chu DI, Balmert LC, Arkin CM, Meyer T, Rosoklija I, Li B et al (2019) Estimated kidney function in children and young adults with spina bifida: a retrospective cohort study. Neurourol Urodyn 38:1907–1914
Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S et al (2006) Derivation and valiation of cystatin C based prediction equations for GFR in children. Am J Kidney Dis 48:221–230
Ouyang L, Bolen J, Valdez R, Joseph D, Baum MA, Thibadeau J (2015) Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol 193:558–564
Veenboer PW, Bosch JL, van Asbeck FW, de Kort LM (2012) Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One 7:e48399
Liu JS, Greiman A, Casey JT, Mukherjee S, Kielb SJ (2016) A snapshot of the adult spina bifida patient - high incidence of urologic procedures. Cent European J Urol 69:72–77
Adams CM, Misseri R, Roth JD, Whittam BM, Guckien ZE, King SJ, Kaefer M, Rink RC, Szymanski KM (2022) Age-based risk of end-stage kidney disease in patients with myelomeningocele. J Pediatr Urol 19:195.e1-195.e7
Filler G, Gharib M, Casier S, Lödige P, Ehrich JH, Dave S (2012) Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol 44:817–827
Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H (2006) Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele. Neurourol Urodyn 25:758–762
Hobbs KT, Krischak M, Tejwani R, Purves JT, Wiener JS, Routh JC (2021) The importance of early diagnosis and management of pediatric neurogenic bladder dysfunction. Res Rep Urol 13:647–657
Fairchild RJ, Aksenov LI, Hobbs KT, Krischak MK, Kaplan SJ, Purves JT, Wiener JS, Routh JC (2022) Medical management of neurogenic bladder in patients with spina bifida: a scoping review. J Pediatr Urol 19:55–63
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Doğan, Ç.S., Taner, S., Tiryaki, B.D. et al. Characteristics and predictors of chronic kidney disease in children with myelomeningocele: a nationwide cohort study. Pediatr Nephrol 39, 1509–1519 (2024). https://doi.org/10.1007/s00467-023-06212-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-06212-5